Search

Peptide

Reference library

Educational peptide reference — research use only.

Research & educational use only

For laboratory and educational research only. Not for human or veterinary consumption. This is not medical advice. Always follow applicable laws and consult qualified professionals.

The calculator performs unit math for research reference. It must not be used to plan or guide dosing in humans or animals. Verify all figures independently in your lab protocol.

SS-31

A mitochondria-targeted peptide studied in oxidative-stress research.

Half-life (approx.)
~hours (approx., subQ)
Diluent
Bacteriostatic water (0.9% benzyl alcohol)
Common vials
5, 10, 50 mg

Half-life figures are literature approximations for educational reference — not pharmacokinetic advice.

Overview

SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide that concentrates in the inner mitochondrial membrane, studied in heart-failure and rare-disease trials. It binds cardiolipin and reduces mitochondrial reactive oxygen species in preclinical models. Elamipretide — mitochondrial-targeted tetrapeptide binding cardiolipin in inner membrane.

Structure & identity

Aromatic-cationic tetrapeptide D-Arg-Dmt-Lys-Phe-NH2 (elamipretide)

Sequence / structure
Aromatic-cationic tetrapeptide D-Arg-Dmt-Lys-Phe-NH2 (elamipretide)

Status: Investigational (elamipretide) for mitochondrial diseases.

Mechanism

Investigational (elamipretide) for mitochondrial diseases.

Aromatic-cationic tetrapeptide binds cardiolipin in inner mitochondrial membrane, reducing ROS. ROS reduction and membrane potential preservation studied in heart failure and mitochondrial disease trials.

Studies & clinical programs

  • Heart failure phase trials

    Published research models

    • Peer-reviewed literature documents endpoints under Heart failure phase trials experimental designs.
  • Barth syndrome research

    Published research models

    • Peer-reviewed literature documents endpoints under Barth syndrome research experimental designs.
  • Mitochondrial ROS assays

    Published research models

    • Peer-reviewed literature documents endpoints under Mitochondrial ROS assays experimental designs.

Research models in literature

  • Heart failure phase trials
  • Barth syndrome research
  • Mitochondrial ROS assays

Literature highlights

  • Elamipretide binds cardiolipin in inner mitochondrial membrane to reduce ROS in heart-failure trials.
  • Barth syndrome and mitochondrial myopathy research programs characterize tissue uptake.
  • Mitochondrial membrane potential and ATP production used as cell-based endpoints.

Combination research notes

Mitochondrial research groups SS-31 with MOTS-c and NAD+ pathway compounds.

Key targets & pathways

CardiolipinMitochondrial membraneMitochondrial cristaeATP synthase efficiency

Research areas

Mitochondrial targetingCardiolipinHeart failureOxidative stress

Routes in research literature

Subcutaneous

Also known as

SS31ElamipretideBendaviaSS 31

Stability & storage phases

PhaseConditionGuidance
LyophilizedSealed vial, refrigerated (2–8 °C)Intact lyophilized cake or powder is typically stable for months to years per published stability data; protect from moisture, light, and repeated freeze-thaw of the dry vial.
ReconstitutedBacteriostatic water (0.9% benzyl alcohol), refrigeratedMost aqueous peptide solutions remain usable for approximately 2–4 weeks refrigerated; verify published stability data and label with reconstitution date.
Working aliquotsPre-drawn syringes or microtubes, frozen (−20 °C)Aliquot promptly after mixing to limit freeze-thaw cycles on the main vial; thaw once and use to reduce protease-mediated degradation.

Stability windows are formulation-dependent — verify published data and your lab SOP.

Reconstitution reference table

Vial (mg)Diluent (mL)mcg/mLUnits @ 100 mcgUnits @ 250 mcgUnits @ 500 mcg
522500.041020
1025000.02510
50225000.00.412

U-100 insulin syringe scale (100 units = 1 mL). Illustrative only — not dosing guidance.

Reconstitution steps

  1. Allow vial to reach room temperature (15–30 min)
  2. Swab rubber stopper with alcohol prep pad
  3. Draw calculated bacteriostatic water into syringe
  4. Inject diluent slowly down vial wall — do not spray directly onto cake
  5. Gently swirl until fully dissolved — do not shake vigorously
  6. Label with date, concentration, and diluent volume
  7. Refrigerate and use within your lab stability window

Typically reconstituted with 1–2 mL bacteriostatic water.

Laboratory record checklist

  • Compound identity recorded in lab notebook (name, lot, preparation date)
  • Analytical identity cross-checked against published sequence or structure
  • Potency or concentration documented from analytical certificate when available
  • Purity or HPLC data filed when provided with research material
  • Appearance noted: intact lyophilized cake or uniform powder
  • Sterility / endotoxin report archived when available
  • Storage temperature applied immediately per published stability guidance